| dc.contributor.author | Walsh, Garry Michael | |
| dc.date.accessioned | 2013-04-26T11:30:00Z | |
| dc.date.available | 2013-04-26T11:30:00Z | |
| dc.date.issued | 2012-03 | |
| dc.identifier | 12376619 | |
| dc.identifier | 21d1894a-3e55-451b-a11c-1648076c3578 | |
| dc.identifier | 84858984498 | |
| dc.identifier.citation | Walsh , G M 2012 , ' An update on emerging drugs for asthma ' , Expert Opinion on Emerging Drugs , vol. 17 , no. 1 , pp. 37-42 . https://doi.org/10.1517/14728214.2012.657625 | en |
| dc.identifier.issn | 1472-8214 | |
| dc.identifier.uri | http://hdl.handle.net/2164/2818 | |
| dc.format.extent | 6 | |
| dc.format.extent | 95232 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Expert Opinion on Emerging Drugs | en |
| dc.subject | asthma | en |
| dc.subject | IL-13 | en |
| dc.subject | IL-4 | en |
| dc.subject | IL-5 | en |
| dc.subject | RM Therapeutics. Pharmacology | en |
| dc.subject.lcc | RM | en |
| dc.title | An update on emerging drugs for asthma | en |
| dc.type | Journal item | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.description.status | Peer reviewed | en |
| dc.identifier.doi | 10.1517/14728214.2012.657625 | |
